NYSE:RDY
Dr Reddy's Laboratories Ltd Stock News
$74.55
+0.530 (+0.716%)
At Close: Apr 26, 2024
Here's Why Doctor Reddy's (RDY) is a Strong Value Stock
10:41am, Wednesday, 20'th Mar 2024
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why Doctor Reddy's (RDY) is a Top Value Stock for the Long-Term
10:41am, Wednesday, 28'th Feb 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here's Why Doctor Reddy's (RDY) is a Strong Momentum Stock
10:56am, Friday, 23'rd Feb 2024
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why Doctor Reddy's (RDY) is a Top Growth Stock for the Long-Term
10:51am, Thursday, 22'nd Feb 2024
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why Doctor Reddy's (RDY) is a Top Momentum Stock for the Long-Term
10:51am, Monday, 05'th Feb 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Dr. Reddy's (RDY) Q3 Earnings and Revenues Surpass Estimates
10:06am, Thursday, 01'st Feb 2024
Dr. Reddy's (RDY) reports better-than-expected fiscal third-quarter 2024 results where both earnings and revenues beat estimates, driven by growth in core businesses in North America and Europe.
3 Generic Drug Stocks to Watch Amid Improving Market Prospects
11:36am, Thursday, 25'th Jan 2024
With the ease in inflationary pressure, the Zacks Medical - Generic Drugs industry is expected to benefit from declining costs. New product launches provide some respite to AMPH, RDY and TEVA.
Here's Why Doctor Reddy's (RDY) is a Strong Growth Stock
11:22am, Monday, 08'th Jan 2024
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
How to Identify Stock Market Winners Early in 2024
12:01pm, Wednesday, 03'rd Jan 2024
With every year comes a different market theme.
Here's Why Doctor Reddy's (RDY) is a Strong Momentum Stock
11:17am, Friday, 08'th Dec 2023
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Dr. Reddy's (RDY), COYA Ink Deal to Develop COYA 302 for ALS
09:02am, Thursday, 07'th Dec 2023
Dr. Reddy's (RDY) enters into a licensing agreement with Coya Therapeutics to develop and commercialize the latter's ALS investigational combination therapy, COYA 302.
India's Dr. Reddy's R&D centre being inspected by US FDA
04:41am, Tuesday, 05'th Dec 2023
India's Dr Reddy's on Tuesday said that its research and development centre in Hyderabad is being inspected by the U.S. Food and Drug Administration.
2 overlooked stocks that crushed earnings but traded lower
06:22am, Monday, 20'th Nov 2023
As the third quarter 2023 earnings season ends, it's worth looking back to see which stocks may have been overlooked or mispriced on their results. Regardless of sector or industry, every earnings sea
Why Doctor Reddy's (RDY) is a Top Value Stock for the Long-Term
11:26am, Thursday, 02'nd Nov 2023
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
3 Generic Drug Stocks to Watch Amid Improving Market Prospects
11:17am, Monday, 30'th Oct 2023
The impact of macroeconomic headwinds on the Zacks Medical - Generic Drugs industry is gradually improving. New product launches provide some respite to RDY, AMPH and SLGL.
